Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine lipid-lowering composition, it has good lipid-lowering effect, and does not have the side effect of Western medicine lipid lowerers, need not periodic review liver function regulating liver-QI biochemical indicator in the medication interval.
Another object of the present invention provides a kind of preparation method of Chinese medicine lipid-lowering composition.
The invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100-300 weight portion Radix Astragali, 100-300 weight portion Herb Gynostemmae Pentaphylli, 100-300 weight portion Radix Salviae Miltiorrhizae and 100-300 weight portion Folium Nelumbinis.
According to a preferred embodiment of the invention, the invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100-300 weight portion Radix Astragali, 100-300 weight portion Herb Gynostemmae Pentaphylli, 100-300 weight portion Radix Salviae Miltiorrhizae, 100-300 weight portion Folium Nelumbinis and 100-300 weight Rhizoma Polygoni Cuspidati.
According to a preferred embodiment of the invention, the invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100-300 weight portion Radix Astragali, 100-300 weight portion Herb Gynostemmae Pentaphylli, 100-300 weight portion Radix Salviae Miltiorrhizae, 100-300 weight portion Folium Nelumbinis, 100-300 weight portion Rhizoma Polygoni Cuspidati, 100-300 weight portion Radix Codonopsis, 100-300 weight portion Semen Cassiae and 100-300 weight portion Fructus Crataegi.
According to a preferred embodiment of the present invention, the invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100-300 weight portion Radix Astragali, 100-300 weight portion Herb Gynostemmae Pentaphylli, 100-300 weight portion Radix Salviae Miltiorrhizae, 100-300 weight portion Folium Nelumbinis, 100-300 weight portion Rhizoma Polygoni Cuspidati, 100-300 weight portion Radix Codonopsis, 100-300 weight portion Semen Cassiae, 100-300 weight portion Fructus Crataegi, 100-300 weight portion Poria and 100-300 weight portion Rhizoma Alismatis.
According to a preferred embodiment of the present invention, the invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100-200 weight portion Radix Astragali, 100-200 weight portion Herb Gynostemmae Pentaphylli, 100-200 weight portion Radix Salviae Miltiorrhizae, 100-200 weight portion Folium Nelumbinis, 100-200 weight portion Rhizoma Polygoni Cuspidati, 100-200 weight portion Radix Codonopsis, 100-200 weight portion Semen Cassiae, 100-200 weight portion Fructus Crataegi, 100-200 weight portion Poria and 100-200 weight portion Rhizoma Alismatis.
According to a preferred embodiment of the present invention, the invention provides a kind of antiatheroscloresis medicine compounds, it is the preparation of being made by the raw material of group raw medicinal herbs under comprising: the 100 weight portion Radixs Astragali, 100 weight portion Herb Gynostemmae Pentaphylli, 100 weight portion Radix Salviae Miltiorrhizaes, 100 weight portion Folium Nelumbinis, 100 weight portion Rhizoma Polygoni Cuspidati, 100 weight portion Radix Codonopsis, 100 weight portion Semen Cassiaes, 100 weight portion Fructus Crataegis, 100 weight portion Poria and 100 weight portion Rhizoma Alismatis.
Preferably, antiatheroscloresis medicine compounds of the present invention is the form of granule.
The present invention also provides the preparation method of antiatheroscloresis medicine compounds, comprises following steps:
1) alcohol reflux that the Radix Astragali and/or Herb Gynostemmae Pentaphylli and/or Rhizoma Alismatis and/or Semen Cassiae and/or Rhizoma Polygoni Cuspidati and/or Folium Nelumbinis is added the 60-80% that 6-8 doubly measures extracts, and filters, and concentrates;
2) Poria and/or Radix Codonopsis and/or Radix Salviae Miltiorrhizae and/or Fructus Crataegi add the decocting that 10-14 doubly measures and boil, and filter, concentrate, and centrifugal;
3) the centrifugal supernatant that obtains the concentrated solution and 2 that obtains merging 1)).
The method according to this invention further comprises the just step of medicine concentrated solution granulation.
The present invention also provides compositions of the present invention to be used for the treatment of purposes in the medicament of hyperlipemia in preparation.
Pharmaceutical composition of the present invention has following function: invigorating spleen to remove dampness, expelling phlegm and resolving turbidity are used for the dizziness uncomfortable in chest due to the wet resistance of insufficiency of the spleen leading to overabundance of dampness, the expectorant stasis of blood, the resistance of the rheumatism stasis of blood, gastral cavity painful abdominal mass abdominal distention, fatigue and weakness.
Hyperlipemia belongs to Chinese medicine " cream fat ", " phlegm-damp ", the category of " expectorant is turbid ". how quiet few moving mostly because improper diet,, feelings will stimulates, and old, plain body obesity or obstinate disease, causes cream fat to take in, generate too much, trans-utilization is too late, due to the acatharsia.Basic reason is visceral dysfunction, and is especially in close relations with liver,spleen,kidney.
Antiatheroscloresis medicine compounds of the present invention is when prescription, strict is to instruct according to Chinese medical theory, though there is not the name of " blood fat " at motherland's medical science, but the characteristics that the reality of blood fat is arranged, with " cream fat " is object of study, theory according to the traditional Chinese medical science " homogeny of clear fluid and blood ", consider that body fluid and blood all derive from diet water paddy, and can transform mutually, " cream fat " as one of body fluid composition also can change life mutually with blood, therefore can use the qi-blood-body fluid theory of the traditional Chinese medical science, cream fat theory is a theoretical foundation, analyze, understanding, the treatment hyperlipemia presses scientific principle to discuss the blood fat reducing medicine that prescription is developed according to the modern times merely on this point and the present market, health product have the difference of essence, are one of main characteristics of this medicine.
The hyperlipemia that antiatheroscloresis medicine compounds of the present invention is treated, be primarily aimed at traditional Chinese medical science insufficiency of the spleen leading to overabundance of dampness, the basic pathogenesis of phlegm and blood stasis, from expectorant, wet, empty, the stasis of blood is seted forth one's views, with strengthening vital QI to eliminate pathogenic factors, treating both the principal and secondary aspects of a disease, increase except being thought of as blood fat during clinical practice, outside the height, also further at the basic pathogenesis of the traditional Chinese medical science, this makes this medicine at symptomatic treatment, disease is treated, the doing well,improving aspect has other single verifications or disease is treated, perhaps have the difference of essence based on the other kinds blood fat-reducing product that improves symptom, this is we's a characteristic, also by the advantage place of product.
Antiatheroscloresis medicine compounds of the present invention is in when research and development, and multidigit has picked up the advantage of above-mentioned these medicines in all directions, and by selected medical material, reasonable compatibility, scientific composition, the strict means such as technology of concocting, select when the best have been avoided its weak point again.This just makes this product have higher curative effect and clinical specific aim, has eliminated the toxic and side effects and the untoward reaction of medicine.We's main constituent is the Radix Astragali, Radix Codonopsis, Herb Gynostemmae Pentaphylli, Poria, Rhizoma Alismatis, Semen Cassiae, Rhizoma Polygoni Cuspidati, Radix Salviae Miltiorrhizae, Fructus Crataegi, Folium Nelumbinis, pure Chinese medicinal preparation, above clinical drug is used thousand, have no side effect and the report of untoward reaction, these have increased this security of products.
Antiatheroscloresis medicine compounds of the present invention has two distinguishing features
1. show by acute, chronic, toxicity test, but long-term prescription does not need the periodic review liver function.
2. transaminase lowering class index there is remarkable therapeutical effect.
Acute toxicity testing shows, antiatheroscloresis medicine compounds of the present invention is with gastric infusion continuously in the dose of the tolerant Cmax of animal, maximum volume one day, maximum dosage-feeding is 272.0 gram crude drug/kilograms, be equivalent to 418.5 times of clinical medicine dose, the reaction of observation experiment animal after the administration, observed 7 days continuously, it is unusual not find that animal body death, form, function, activity etc. occur.
On this basis, we carried out again long term toxicity test the blood fat reducing granule by the dosage of 34.0,17.0,8.5 gram crude drug/kilogram/days (50 times, 25 times, 12.5 times of clinical medicine dose that are equivalent to the people) respectively to laboratory animal filling stomach, 26 weeks of continuous irrigation stomach, convalescent period observed 1 month, the result shows that this product does not have influence to the ordinary circumstance of laboratory animal.The high dose group rat body weight increasess slowly; Administration 3 months, after the drug withdrawal second day, each multinomial blood biochemical of group institute's rat peripheral hemogram and serum etc. surveyed index of convalescent period administration all fluctuates in normal range, serum total cholesterol content obviously reduces, and the function of this and this medicine cures mainly identical. and the ponderal index to important organ does not have obvious influence.The tissue morphology of the activity of perusal laboratory animal, pathological anatomy laboratory animal, all no abnormal.Above toxicologic study provides the application foundation for the safe medication of this product.
The specific embodiment
Preparation embodiment 1
The 200g Radix Astragali, 200g Herb Gynostemmae Pentaphylli and 200g Folium Nelumbinis add 70% ethanol of 7 times of amounts, reflux, extract, 3 times, and each 2 hours, filter and merge ethanol liquid, reclaim ethanol and also be concentrated into the concentrated solution that relative density is 1.10-1.30 (60 ℃).The 200g Radix Salviae Miltiorrhizae adds the water of 12 times of amounts, decocts each 1 hour 3 times, filter, merge decocting liquid, be concentrated into relative density 1.10-1.30 (60 ℃) Shi Fangleng, centrifugal (2500rpm.20min) gets supernatant and above-mentioned concentrated solution merges, and continues to be concentrated into the thick paste that relative density is 1.30-1.40, drying under reduced pressure, grind into fine powder, it is an amount of to add aspartame and dextrin, and mixing is with the alcohol granulation of debita spissitudo, drying, promptly.
Preparation embodiment 2
The 200g Radix Astragali, 100g Herb Gynostemmae Pentaphylli, 300g Rhizoma Polygoni Cuspidati and 300g Folium Nelumbinis add 60% ethanol of 8 times of amounts, reflux, extract, 4 times, and each 1.5 hours, filter and merge ethanol liquid, reclaim ethanol and also be concentrated into the concentrated solution that relative density is 1.10-1.30 (60 ℃).The 300g Radix Salviae Miltiorrhizae adds the water of 14 times of amounts, decocts each 1 hour 3 times, filter, merge decocting liquid, be concentrated into relative density 1.10-1.30 (60 ℃) Shi Fangleng, centrifugal (2500rpm.20min) gets supernatant and above-mentioned concentrated solution merges, and continues to be concentrated into the thick paste that relative density is 1.30-1.40, drying under reduced pressure, grind into fine powder, it is an amount of to add aspartame and dextrin, and mixing is with the alcohol granulation of debita spissitudo, drying, promptly.
Preparation embodiment 3
The 200g Radix Astragali, 300g Herb Gynostemmae Pentaphylli, 100g Rhizoma Polygoni Cuspidati, 100g Semen Cassiae and 100g Folium Nelumbinis add 80% ethanol of 6 times of amounts, reflux, extract, 2 times, each 3 hours, filter merging ethanol liquid, reclaim ethanol and also be concentrated into the concentrated solution that relative density is 1.10-1.30 (60 ℃).100g Radix Salviae Miltiorrhizae, 300g Radix Codonopsis and 100g Fructus Crataegi add the water of 10 times of amounts, decoct each 1.5 hours 2 times, filter, merge decocting liquid, be concentrated into relative density 1.10-1.30 (60 ℃) Shi Fangleng, centrifugal (2500rpm.20min) gets supernatant and above-mentioned concentrated solution merges, and continues to be concentrated into the thick paste that relative density is 1.30-1.40, drying under reduced pressure, grind into fine powder, it is an amount of to add aspartame and dextrin, and mixing is with the alcohol granulation of debita spissitudo, drying, promptly.
Preparation embodiment 4
The 200g Radix Astragali, 200g Herb Gynostemmae Pentaphylli, 200g Rhizoma Alismatis, 200g Semen Cassiae, 200g Rhizoma Polygoni Cuspidati and 200g Folium Nelumbinis add 70% ethanol of 7 times of amounts, reflux, extract, 3 times, each 2 hours, filter merging ethanol liquid, reclaim ethanol and also be concentrated into the concentrated solution that relative density is 1.10-1.30 (60 ℃).200g Poria, 200g Radix Codonopsis, 200g Radix Salviae Miltiorrhizae and 200g Fructus Crataegi add the water of 12 times of amounts, decoct each 1 hour 3 times, filter, merge decocting liquid, be concentrated into relative density 1.10-1.30 (60 ℃) Shi Fangleng, centrifugal (2500rpm.20min) gets supernatant and above-mentioned concentrated solution merges, and continues to be concentrated into the thick paste that relative density is 1.30-1.40, drying under reduced pressure, grind into fine powder, it is an amount of to add aspartame and dextrin, and mixing is with the alcohol granulation of debita spissitudo, drying, promptly.
Effect embodiment 1
The present invention is prepared blood fat reducing granule 14.4,7.2,3.6g crude drug/kg body weight that embodiment 4 makes to irritate stomach and gives mice; 7.2,3.6,1.8g crude drug/kg body weight irritates stomach and gives rat; no matter prevent administration or treat administration; all obviously reduce because of eating due to the high lipid food T-CHOL, triglyceride, low-density lipoprotein cholesterol content and high density lipoprotein increasing content of cholesterol in the hyperlipidemia rats serum for a long time; reduce whole blood viscosity, 10% macromolecule right rotary glycoside induced mice microcirculation disturbance is had significant protective effect.Have the effect of stronger prevention and treatment hyperlipidemia and reduce the function of whole blood viscosity, microcirculation improvement.
Experiment material
Animal: the Wistar rat, body weight 250-270g, male; CD-1 (1CR) mice, male, animal quality certification SCXK (capital) 2002-0003 is provided by Beijing Vital River Experimental Animals Technology Co., Ltd..
The dosage design: the clinical people's consumption per day of blood fat reducing granule is the 39g crude drug, presses 60kg and calculates, be i.e. 0.65g crude drug/kg/d.Press the conversion of animals and human beings kg body weight dose,equivalent, mice is used 3.6g crude drug/kg/d (5.5 times) with 7.2g crude drug/kg/d (11.0 times), rat, and being equivalent to clinical equivalent dosage is middle dosage, and high dose is 2 times of middle dosage, and low dosage is 1/2 times of middle dosage.Be that the people Mus irritates that stomach dosage power 7.2,3.6,1.8g crude drug/kg, mouse stomach dosage are 14.4,7.2,3.6g crude drug/kg.
Positive control drug: JIANGZHILING, Dongang Pharmaceutical Co., Ltd., Shenyang produces, lot number: 020101, clinical people's consumption per day is 13.98, animals administer dosage is by the conversion of animal people kg body weight, give 2 times of amounts that rat is equal to clinical equivalent dosage by 2.5g/kg, give 2 times of amounts that mice is equal to clinical equivalent dosage by 5.0g/kg.
Experimental technique and result
1. the blood fat reducing granule is to the influence of serum lipids in rats
1.1 the blood fat reducing granule is to the preventive effect of serum lipids in rats: get the Wistar rat, body weight 260 ± 10g, male, be divided into 6 groups at random, 10 every group.Survey normal CHO value earlier.Except that the normal control group, all the other each groups are all fed with high lipid food (3% cholesterol, 10% Adeps Sus domestica, 0.2% sodium cholate, 0.2% propylthiouracil, 86.6% normal feedstuff) continuous 4 weeks, cause hyperlipemia model.Modeling begins gastric infusion simultaneously, (1ml/100g body weight, normal control and model group filling stomach give the distilled water with volume) once a day, continuous 4 weeks.Before experiment finishes, animal fasting 12 hours, the ventral aorta blood sampling, whole blood viscosity is surveyed in the anticoagulant of 3ml blood, and 2ml blood is centrifugal with 3000 rev/mins, and separation of serum is pressed the test kit explanation and is measured CHO, TG, LDL-C and HDL-C content in the serum.Carry out statistical procedures with the t check.
Table 1 blood fat reducing granule prevention administration is to the influence (n=10) of hyperlipidemia rats blood fat (X ± SD)
Group | Dosage g/mg | CHO (mmol/L) before the administration | Blood fat behind the medicine |
CHO (mmol/L) | TG (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) |
Matched group model group JIANGZHILING blood fat reducing granule | - - 2.5 7.2 3.6 1.8 | 2.88±0.61 2.83±0.87 2.97±0.38 2.91±0.67 2.86±0.71 2.93±0.54 | 2.53±0.66 7.01±2.54## 4.38±1.34
** 4.30±1.14
** 4.53±1.16
* 4.93±1.79
| 0.72±0.30 1.55±0.66## 0.95±0.31
* 0.82±0.30
** 0.96±0.47
* 1.02±0.72
| 1.41±0.84 6.55±3.41## 3.41±1.65
* 2.92±1.44
** 3.27±1.28
* 3.50±2.31
* | 1.13±0.32 0.53±0.12## 0.74±0.23
* 0.79±0.28
* 0.72±0.26
* 0.70±0.23
|
Compare ##p<0.01 compares with model group with matched group
*P<0.05,
*P<0.01
Table 2 blood fat reducing granule prevention administration is to the influence of hyperlipidemia rats whole blood viscosity (X ± SD)
Group | Dosage g/mg | N | Whole blood viscosity (shear rate l/s) |
5 | 10 | 38 | 150 |
Matched group model group JIANGZHILING blood fat reducing granule | - - 2.5 7.2 3.6 1.8 | 10 10 10 10 10 10 | 9.92±0.43 12.5±1.35## 11.1±1.53 10.7±1.17
** 10.8±1.33
* 11.4±2.53
| 7.40±0.21 9.12±0.97## 8.16±1.05
* 7.93±0.75
** 7.92±0.93
* 8.30±1.63
| 4.90±0.18 5.86±0.64## 5.30±0.68 5.18±0.41
* 5.09±0.58
* 5.26±0.83
| 3.81±0.21 4.44±0.51## 4.04±0.52 3.98±0.31
* 3.86±0.44
* 3.94±0.54
* |
Compare ##P<0.01 with matched group and compare p<0.05 with model group,
*P<0.01
Table 1 result as seen, model group rat blood serum T-CHOL, triglyceride, low-density lipoprotein cholesterol content are compared significantly with matched group and are increased, HDL-C is compared remarkable reduction with matched group, the blood fat reducing granule obviously reduces hyperlipemia rat serum total cholesterol, triglyceride, low-density lipoprotein cholesterol content, the high density lipoprotein increasing cholesterol, high, middle dosage group is compared with model group, p<0.05 or p<0.01.
Table 2 result shows that model group rat whole blood viscosity obviously increases, and blood fat reducing granule height, middle dosage group all can significantly reduce the rat whole blood viscosity.Show the prevention rat fat rising that the blood fat reducing granule can be wicked and improve blood circulation.
1.2 the blood fat reducing granule is to the therapeutical effect of serum lipids in rats: get the Wistar rat, body weight 260 ± 10g, male, be divided into 6 groups at random, 10 every group.Except that the normal control group, all the other each groups are all fed with high lipid food (3% cholesterol, 10% Adeps Sus domestica, 0.2% sodium cholate, 0.2% propylthiouracil, 86.6% normal feedstuff) continuous 4 weeks, cause hyperlipemia model.After two weeks of modeling, it is centrifugal earlier to get rat serum from the socket of the eye vein, does serum total cholesterol determination, beginning gastric infusion, (1ml/100g body weight, normal control and model group are irritated stomach and given distilled water with volume) once a day, continuous 2 weeks.Before experiment finishes, animal fasting 12 hours, the rat aorta blood sampling, the 3ml anticoagulated whole blood is surveyed whole blood viscosity, 2ml blood with 3000 rev/mins centrifugal 10 minutes, separation of serum press CHO, TG, LDL-C and HDL-C content in the test kit explanation mensuration serum.Carry out statistical procedures with the t check.
The administration of table 3 blood fat reducing granule therapy is to the influence (n=10) of hyperlipidemia rats blood fat (X ± SD)
Group | Dosage g/kg | CHO (mmol/L) before the administration | Blood fat behind the medicine |
CHO (mmol/L) | TG (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) |
Matched group model group JIANGZHILING blood fat reducing granule | - - 2.5 7.2 3.6 1.8 | 3.13±1.59 9.48±2.53## 10.63±4.24## 10.62±3.28## 10.41±2.86## 9.91±2.66## | 2.87±0.77 7.56±2.13## 5.07±1.51
** 4.04±1.96
** 4.65±2.01
** 4.76±2.52
* | 1.83±0.58 3.23±0.57## 2.13±0.85
** 2.38±0.61
** 2.19±0.79
** 2.43±0.77
| 2.27±0.78 6.25±1.97## 4.23±1.53
* 3.33±1.91
** 3.76±1.99
* 3.85±2.59
* | 0.96±0.35 0.54±0.22## 0.81±0.23
* 0.71±0.11
* 0.59±0.19
* 0.77±0.22
* |
Compare ##p<0.01 compares with model group with matched group
*P<0.05,
*P<0.01
The administration of table 4 blood fat reducing granule therapy is to the influence (X+SD) of hyperlipidemia rats whole blood viscosity
Group | Dosage g/kg | N | Whole blood viscosity (shear rate l/s) |
5 | 10 | 38 | 150 |
Matched group model group JIANGZHILING blood fat reducing granule | - - 2.5 7.2 3.6 1.8 | 10 10 10 10 10 10 | 9.96±1.85 13.2±1.69## 11.4±1.81
* 10.1±2.16
** 11.2±1.67
* 10.9±1.56
** | 7.42±1.32 9.42±1.00## 8.39±1.05
* 7.44±1.55
** 8.07±1.12
* 7.93±0.97
| 4.91±0.82 5.83±0.62# 5.37±0.70 4.87±0.88
* 5.07±0.66
* 5.07±0.51
* | 3.71±0.45 4.31±0.60# 4.04±0.63 3.72±0.65 3.78±0.51 3.83±0.40 |
Compare #p<0.05 with matched group, p<0.05 is compared with mould punishment group in ##p<0.01,
*P<0.01
Table 3,4 results as seen, after two weeks of modeling, rat blood serum T-CHOL value obviously raises, there was no significant difference between five groups of modeling groups.After two weeks of blood fat reducing granule gastric infusion, institute's amount of reagent all can obviously reduce hyperlipemia rat serum total cholesterol, triglyceride, low-density lipoprotein cholesterol content, the high density lipoprotein increasing cholesterol level, obviously reduce the rat whole blood viscosity, show that the blood fat reducing granule has therapeutical effect preferably to serum lipids in rats.
2. the blood fat reducing granule influences mice and is divided into 5 groups at random by body weight mice is microcirculatory, continuous three days gastric infusions, and behind the last medicine 1 hour, 0.5% pentobarbital sodium 0.2ml/20g anaesthetized by 50mg/kg dosage lumbar injection.Cut off the mice tragus, be placed on the microscope carrier, select the identical venule of Mus ear same position flow velocity to observe, and blood flow rate before the record modeling.Caudal vein is injected 10% macromolecule right rotary glycoside 1mg/kg and is caused the circulatory disturbance model, observes and writes down blood flow rate immediately and return to time of normal blood flow, return to the normal time less than 0.5 minute by 0.5 minute, greater than 30 minutes by 30 minutes.Blood flow rate and recovery time are carried out statistical procedures with check.
The flow velocity criterion:
Linear flow: blood flow is fast, is smooth streak, and no granular sensation is decided to be 4;
Line grain stream: blood flow is very fast, is streak, and granular sensation is arranged slightly, is decided to be 3;
The grain linear flow: blood flow is slower, though be line continuously, obvious grain sense is arranged, and is decided to be 2;
The grain unhurried current: blood flow is the silt sample, and sluggish flow is decided to be 1 continuously;
Grain pendulum stream: blood flow is the silt shape, though flow forward, swing is decided to be 0.5;
Stagnate: blood flow is stagnated motionless, is decided to be 0.
Table 5 blood fat reducing granule is to the microcirculatory influence of mice
Group | Dosage (g/kg) | Mus number (only) | Blood flow rate | Recovery time |
Before the modeling | After the modeling | (branch) |
Matched group | - | 10 | 3.8±0.42 | 0.90±0.46 | 21.5±4.25 |
The blood fat reducing granule | 10.8 | 10 | 3.8±0.42 | 1.70±0.48
** | 16.5±5.70
* |
| 5.4 | 10 | 3.7±0.48 | 1.50±0.53
* | 16.2±5.03
* |
| 2.7 | 10 | 3.8±0.42 | 1.45±0.60
* | 16.9±7.37 |
Annotate: matched group is compared,
*P<0.05,
*P<0.01
Table 5 result as can be seen, the blood fat reducing granule has significant protective effect to 10% macromolecule right rotary glycoside induced mice microcirculation disturbance.Blood flow rate is obviously accelerated, and obviously shortened restoration of blood flow to the normal time.
Experimental result
Blood fat reducing granule 14.4,7.2,3.69 crude drugs/kg body weight are irritated stomach and are given mice; 7.2,3.6,1.8g crude drug/kg body weight irritates stomach and gives rat; no matter prevent administration or treat administration; all obviously reduce because of eating due to the high lipid food T-CHOL, triglyceride, low-density lipoprotein cholesterol content and high density lipoprotein increasing content of cholesterol in the hyperlipidemia rats serum for a long time; reduce the whole blood viscosity of hyperlipidemia rat, 10% macromolecule right rotary glycoside induced mice microcirculation disturbance is had significant protective effect.Blood flow rate is obviously accelerated, and obviously shortened the normal time of restoration of blood flow, high, middle dosage effect is obvious.Have stronger effect for reducing blood fat and improve the blood circulation function.